Navigation Links
Edwards Lifesciences Announces Organizational Changes
Date:2/18/2008

IRVINE, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, today announced the company's strengthened alignment into a business unit organizational structure, along with the planned departure in the middle of 2008 of corporate officers Anita B. Bessler, Stuart L. Foster, and Alex Martin.

"To support our growth strategy, we have recently made product portfolio changes and increased investment in our market-leading businesses. As a result, we can now further our evolution into customer-focused business units and simplify our organization," said Michael A. Mussallem, Edwards' chairman and CEO. "We express our sincere thanks and gratitude to Anita, Stu and Alex for their significant contributions to Edwards over the years. Consistent with our Credo, they have served as trusted partners with patients, employees, customers and shareholders to provide innovative solutions for people fighting cardiovascular disease."

Bessler, who joined the company in 1988 and led the growth of Edwards' heart valve business into its current position as the global market leader, will continue in an ongoing advisory role with Edwards.

Foster, who joined the company in 1994 and served as the company's technology leader and oversaw the development and growth of the critical care and vascular businesses, will also continue in an ongoing advisory role with Edwards.

Martin, who joined Edwards in 2004, plans to pursue other opportunities upon his departure. He oversaw the development and expansion of the company's North American sales and marketing organization, Edwards' largest operating region.

As a result of the ope
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
2. Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
3. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
4. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
5. Edwards Lifesciences Forecasts Strong Growth in 2008
6. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
7. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
10. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
11. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...RUSSIA, Pa., Nov. 30 Cadient Inte...n interactive marketing services and solutions fo...nch of its HATCH Consulting services group (...ategic experts across a range of emerging areas of...ng team is committed to guiding companies and bran...
(Date:11/30/2009)...ovember 30 Biopharmaceutical compa...tients have been enrolled in its,multinational reg...is,designed to show reduction in transplant relate...geneic stem cell transplantation with a mismatched...eligible for an allogeneic,stem cell transplantati...
(Date:11/30/2009)..., a leader in providing smart and efficient softwa...Pathology®, evolutionizing work-from-home hist...ard’ software used by 8 of the Top 10 Pharma...ost per slide’ basis. , ... -- PDS has announced another evolution in the his...
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNewswire-Fir... of scientific, medical and technical products and...base, its comprehensive biomedical,database which ...an 7,000,active, peer reviewed journals. , ...ment of new biomedical,and pharmaceutical insights...
Breaking Biology Technology:Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3
...: INSM ), a biopharmaceutical company, today rep..., 2009. , , Recent Company Highlights , , , ... Finalized sale of follow-on biologics (FOB) as...e, for gross proceeds of $130 million; and , ...s received net proceeds to date of approximately $...
...egy and Process for Picoplatin - , , SOUTH SAN FR...Inc. (Nasdaq: PARD ), a biopharmaceutical compan...announced that Ronald Martell, president and chief...ational Convention on Tuesday, May 19, at 3:20 p.m...de an overview of the Company,s lead product candi...
...y leader to acquire 105 MGY of additional capacity.... , Ames, Iowa (Vocus) Ma...nounced it has entered into agreements to consolid...Western Iowa Energy, which operates a 30 MGY facil...which operates a 30 MGY facility Newton, Iowa; and...
Other Biology Technology:Insmed Announces First Quarter 2009 Financial Results 2Insmed Announces First Quarter 2009 Financial Results 3Insmed Announces First Quarter 2009 Financial Results 4Insmed Announces First Quarter 2009 Financial Results 5Insmed Announces First Quarter 2009 Financial Results 6Insmed Announces First Quarter 2009 Financial Results 7Insmed Announces First Quarter 2009 Financial Results 8Insmed Announces First Quarter 2009 Financial Results 9Poniard Pharmaceuticals to Present at the 2009 BIO International Convention 2Poniard Pharmaceuticals to Present at the 2009 BIO International Convention 3REG Signs Agreement with Three Biodiesel Plants to Consolidate 2REG Signs Agreement with Three Biodiesel Plants to Consolidate 3REG Signs Agreement with Three Biodiesel Plants to Consolidate 4REG Signs Agreement with Three Biodiesel Plants to Consolidate 5REG Signs Agreement with Three Biodiesel Plants to Consolidate 6REG Signs Agreement with Three Biodiesel Plants to Consolidate 7
(Date:11/30/2009)...tage of lower early bird registration rates and re...ngress of 2010 at http://www.iofwco-ecceo10.org/ ... the International Osteoporosis Foundation (IOF) a...Aspects of Osteoporosis and Osteoarthritis (ESCEO)...ld are expected to attend. The exciting scientific...
(Date:11/30/2009)...arch report published in the December 2009 print i... similar type of control over their fertility that...ientists have found how and where androgenic hormo...duction and male fertility. This opens a promising... The discovery also offers hope to those who canno...
(Date:11/26/2009)... sharks are some of the Ocean,s most distinctive r...ave this strange head shape, says Michelle McComb...ason is the shark,s vision. ,Perhaps their visual ..., says McComb, giving the sharks excellent stereov...McComb, there were two schools of thought on this ...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52194 1BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52194 2BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52194 3Frost 26 Sullivan Examines the Key Challenges in the European Non Invasive Ventilation Market 52191 1Frost 26 Sullivan Examines the Key Challenges in the European Non Invasive Ventilation Market 52191 2HealthCare Partners of Nevada and Fremont Medical Center Join Forces 52190 1HealthCare Partners of Nevada and Fremont Medical Center Join Forces 52190 2
...ia nurse researcher is among the first in the nati...us funding through the American Recovery and Reinv...nt will support at least three jobs and the resear...ho may suffer from cocaine-related renal disease. ... 3.5 million jobs over the next two years. , "It,...
...as key to Komodo Dragon,s hunting strategy. , A n...omodo Dragon bite is a combination of highly speci...dismiss the widely accepted theory that prey die f...the dragon,s mouth. , Using sophisticated medical...Dr Bryan Fry from the University of Melbourne have...
...the active site found in a naturally occurring enz...escribed a catalyst that acts like nature,s most p...cribe their work in a paper accepted for publicati...y , and posted on the journal,s Web site. , Scient... use cheap and plentiful building blocks iron, ni...
Other Biology News:MCG researcher among first to receive NIH stimulus funding 2A combined tooth-venom arsenal revealed as key to Komodo dragon's hunting strategy 2
GRADIENT MAKER, 30 ML from GE Healthcare, formerly Amersham Biosciences
...rnandez and G. Butcher (1998). • The major hi...search in the immunology area. There is great inte... function as antigen-presenting molecules. Many im...ackling biochemical and genetic techniques in orde...
DALT GRADIENT MAKER,230V from GE Healthcare, formerly Amersham Biosciences
Actin from Molecular Probes (Invitrogen)
Biology Products: